贝达药业 (300558.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(贝达药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 735,775,468.802,456,196,486.622,043,551,452.901,313,877,968.81531,618,547.852,376,629,657.361,662,717,674.701,253,336,956.19584,705,632.04
 营业利润(元) 108,359,629.25270,069,503.79237,023,065.2186,438,503.184,863,487.3594,796,754.2893,992,626.9175,389,639.0997,040,559.52
 利润总额(元) 107,227,308.89322,074,564.19291,784,917.03142,206,982.4935,503,476.5887,571,338.1390,139,948.3172,140,186.6195,809,100.26
 净利润(元) 93,790,802.53333,615,704.19294,122,417.51141,577,333.7247,941,555.34124,763,291.3688,786,170.8386,253,021.5879,272,651.53
 归属于母公司股东的净利润(元) 98,140,741.56348,032,472.42304,692,911.78148,306,337.1951,396,813.71145,420,319.09102,806,507.5794,717,355.0683,678,928.89
盈利能力:
 销售毛利率(%) 82.5383.5385.6584.2085.2888.6988.5888.9387.95
 销售净利率(%) 12.7513.5814.3910.789.025.255.346.8813.56
 净资产收益率(%) 1.886.896.053.041.07----
 总资产报酬率ROA(%) 1.354.243.972.020.73----
 投入资本回报率ROIC(%) 1.254.874.272.130.762.601.981.881.73
营运能力:
 存货周转率(次) 0.361.160.820.580.22----
 应收账款周转率(次) 2.646.835.082.701.62----
 总资产周转率(次) 0.090.290.250.170.07----
偿债能力:
 资产负债率(%) 39.8241.4939.4840.0737.3637.3232.6133.2727.22
 股东权益比率(%) 59.2157.4159.4258.7561.3361.3065.8865.1270.95
 已获利息倍数(倍) 11.789.1411.299.153.001.5013.8632.3739.66
 流动比率 0.910.851.111.271.330.821.491.421.85
 速动比率 0.650.660.871.000.980.641.101.101.41
发展能力:
 营业收入增长率(%) 38.403.3522.904.83-9.085.82-3.588.50-5.47
 营业利润增长率(%) 2,128.02184.89152.1714.66-94.99-76.04-75.49-70.84-44.07
 税后利润增长率(%) 90.95139.33196.3856.58-38.58-62.04-70.36-55.96-43.36
 净资产增长率(%) 12.848.298.797.514.756.326.617.338.89
 总资产增长率(%) 16.8915.6420.6119.1521.1826.1328.8329.0223.11

前瞻产业研究院